Inflammatory cytokines in experimental and human stroke

Journal of Cerebral Blood Flow and Metabolism

Volumn 32, Issue 9, 2012, Pages 1677-1698

  Lambertsen, Kate Lykke ^a   Biber, Knut ^b   Finsen, Bente ^a,b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

focal cerebral ischemia; interleukin 1; interleukin 6; penumbra; therapeutic window; tumor necrosis factor

Indexed keywords

ADENOSINE TRIPHOSPHATE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RECOMBINANT INTERLEUKIN 6; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; TUMOR NECROSIS FACTOR BINDING PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ASTROCYTE; AUTOPSY; BLOOD LEVEL; BRAIN ISCHEMIA; CELL SURFACE; CEREBROSPINAL FLUID LEVEL; CRANIECTOMY; CYTOKINE PRODUCTION; DIFFUSION WEIGHTED IMAGING; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; IMMUNOREACTIVITY; MACROPHAGE; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PERFUSION WEIGHTED IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; REVIEW; STROKE; UPREGULATION;

CEREBRAL INFARCTION; CYTOKINES; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; MICROGLIA; RECEPTORS, CYTOKINE; SIGNAL TRANSDUCTION; STROKE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84865989120     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2012.88     Document Type: Review

References (150)

1. Adibhatla RM, Haatcher JF (2007) Secretory phospholipase A2 IIA is up-regulated by TNF-a and IL-1a/b after transient focal cerebral ischemia in rat. Brain Res 1134:199-205 (Pubitemid 46135540)
2. Allan SM, Tyrrell PJ, Rothwell NJ (2005) Interleukin-1 and neuronal injury. Nat Rev Immunol 5:629-40 (Pubitemid 41113194)
3. Astrup J, Siesjo BK, Symon L (1981) Thresholds in cerebral ischemia-the ischemic penumbra. Stroke 12:723-5 (Pubitemid 12227362)
4. Back T, Hemmen T, Schuler OG (2004) Lesion evolution in cerebral ischemia. J Neurol 251:388-97 (Pubitemid 38501295)
5. Banwell V, Sena ES, Macleod MR (2009) Systematic review and stratified meta-analysis of the efficacy of interleukin-1 receptor antagonist in animal models of stroke. J Stroke Cerebrovasc Dis 18:269-76
6. Barone FC, Arvin B, White RF, Miller A, Webb CL, Willette RN, Lysko PG, Feuerstein GZ (1997) Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke 28:1233-44 (Pubitemid 27248902)
7. Bartsch JW, Wildeboer D, Koller G, Naus S, Rittger A, Moss ML, Minai Y, Jockusch H (2010) Tumor necrosis factoralpha (TNF-alpha) regulates shedding of TNF-alpha receptor 1 by the metalloprotease-disintegrin ADAM8: evidence for a protease-regulated feedback loop in neuroprotection. J Neurosci 30:12210-8
8. Bauer S, Kerr BJ, Patterson PH (2007) The neuropoietic cytokine family in development, plasticity, disease and injury. Nat Rev Neurosci 8:221-32 (Pubitemid 46294661)
9. Beridze M, Sanikidze T, Shakarishvili R, Intskirveli N, Bornstein NM (2011) Selected acute phase CSF factors in ischemic stroke: findings and prognostic value. BMC Neurol 11:41
10. Berti R, Williams AJ, Moffett JR, Hale SL, Velarde LC, Elliott PJ, Yao C, Dave JR, Tortella FC (2002) Quantitative real-time RT-PCR analysis of inflammatory gene expression associated with ischemia-reperfusion brain injury. J Cereb Blood Flow Metab 22:1068-79 (Pubitemid 35006799)
11. Biber K, Pinto-Duarte A, Wittendorp MC, Dolga AM, Fernandes CC, Von Frijtag Drabbe Kunzel J, Keijser JN, de Vries R, Ijzerman AP, Ribeiro JA, Eisel U, Sebastiao AM, Boddeke HW (2008) Interleukin-6 upregulates neuronal adenosine A1 receptors: implications for neuromodulation and neuroprotection. Neuropsychopharmacology 33:2237-50 (Pubitemid 351992084)
12. Botchkina GI, Meistrell ME, III, Botchkina IL, Tracey KJ (1997) Expression of TNF and TNF receptors (p55 and p75) in the rat brain after focal cerebral ischemia. Mol Med 3:765-81 (Pubitemid 28047420)
13. Boutin H, LeFeuvre RA, Horai R, Asano M, Iwakura Y, Rothwell NJ (2001) Role of IL-1alpha and IL-1beta in ischemic brain damage. J Neurosci 21:5528-34 (Pubitemid 32692151)
14. Breder CD, Tsujimoto M, Terano Y, Scott DW, Saper CB (1993) Distribution and characterization of tumor necrosis factor-alpha-like immunoreactivity in the murine central nervous system. J Comp Neurol 337:543-67 (Pubitemid 23323643)
15. Bruce AJ, Boling W, Kindy MS, Peschon J, Kraemer PJ, Carpenter MK, Holtsberg FW, Mattson MP (1996) Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat Med 2:788-94 (Pubitemid 26225095)
16. Buttini M, Appel K, Sauter A, Gebicke-Haerter PJ, Boddeke HW (1996) Expression of tumor necrosis factor alpha after focal cerebral ischaemia in the rat. Neuroscience 71:1-16 (Pubitemid 26041886)
17. Buttini M, Sauter A, Boddeke HW (1994) Induction of interleukin-1 beta mRNA after focal cerebral ischaemia in the rat. Brain Res Mol Brain Res 23:126-34
18. Cardenas A, Moro MA, Leza JC, O'Shea E, Davalos A, Castillo J, Lorenzo P, Lizasoain I (2002) Upregulation of TACE/ADAM17 after ischemic preconditioning is involved in brain tolerance. J Cereb Blood Flow Metab 22:1297-302 (Pubitemid 35285086)
19. Castellanos M, Castillo J, Garc?́a MM, Leira R, Serena J, Chamorro A, Dávalos A (2002) Inflammation-mediated damage in progressing lacunar infarctions: a potential therapeutic target. Stroke 33:982-7 (Pubitemid 34293579)
20. Chang L, Chen Y, Li J, Liu Z, Wang Z, Chen J, Cao W, Xu Y (2011) Cocaine-and amphetamine-regulated transcript modulates peripheral immunity and protects against brain injury in experimental stroke. Brain Behav Immun 25:260-9
21. Chapman KZ, Dale VQ, Denes A, Bennett G, Rothwell NJ, Alland SM, McColl BW (2009) A rapid and transient response precedes brain inflammation after experimental stroke. J Cereb Blood Flow Metab 29:1764-8
22. Cho SH, Sun B, Zhou Y, Kauppinen TM, Halabisky B, Wes P, Ransohoff RM, Gan L (2011) CX3CR1 modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer's disease. J Biol Chem 286:32713-22
23. Clark WM, Rinker LG, Lessov NS, Hazel K, Hill JK, Stenzel-Poore M, Eckenstein F (2000) Lack of interleukin-6 expression is not protective against focal central nervous system ischemia. Stroke 31:1715-20 (Pubitemid 30437528)
24. Clausen BH, Lambertsen KL, Babcock AA, Holm TH, Dagnaes-Hansen F, Finsen B (2008) Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice. J Neuroinflammation 5:46
25. Clausen BH, Lambertsen KL, Meldgaard M, Finsen B (2005) A quantitative in situ hybridization and polymerase chain reaction study of microglial-macrophage expression of interleukin-1beta mRNA following permanent middle cerebral artery occlusion in mice. Neuroscience 132:879-92 (Pubitemid 40602524)
26. Cullinan EB, Kwee L, Nunes P, Shuster DJ, Ju G, McIntyre KW, Chizzonite RA, Labow MA (1998) IL-1 receptor accessory protein is an essential component of the IL-1 receptor. J Immunol 161:5614-20 (Pubitemid 28519127)
27. Davies CA, Loddick SA, Toulmond S, Stroemer RP, Hunt J, Rothwell NJ (1999) The progression and topographic distribution of interleukin-1beta expression after permanent middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 19:87-98 (Pubitemid 29283584)
28. Dawson DA, Martin D, Hallenbeck JM (1996) Inhibition of tumor necrosis factor-alpha reduces focal cerebral ischemic injury in the spontaneously hypertensive rat. Neurosci Lett 218:41-4 (Pubitemid 26366712)
29. del Zoppo GJ, Sharp FR, Heiss WD, Albers GW (2011) Heterogeneity in the penumbra. J Cereb Blood Flow Metab 31:1836-51
30. Denes A, McColl BW, Leow-Dyke SF, Chapman KZ, Humphreys NE, Grencis RK, Allan SM, Rothwell NJ (2011) Experimental stroke-induced changes in the bone marrow reveal complex regulation of leukocyte responses. J Cereb Blood Flow Metab 31:1036-50
31. Dinarello CA (1994) The interleukin-1 family: 10 years of discovery. FASEB J 8:1314-25
32. Dirnagl U, Iadecola C, Moskowitz MA (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22:391-7 (Pubitemid 29453643)
33. Dziewulska D, Mossakowski MJ (2003) Cellular expression of tumor necrosis factor a and its receptors in human ischemic stroke. Clin Neuropathol 22:35-40 (Pubitemid 36152123)
34. Emsley HC, Smith CJ, Gavin CM, Georgiou RF, Vail A, Barberan EM, Illingworth K, Scarth S, Wickramasinghe V, Hoadley ME, Rothwell NJ, Tyrrell PJ, Hopkins SJ (2007) Clinical outcome following acute ischaemic stroke relates to both activation and autoregulatory inhibition of cytokine production. BMC Neurol 7:5
35. Emsley HC, Smith CJ, Georgiou RF, Vail A, Hopkins SJ, Rothwell NJ, Tyrrell PJ (2005) A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients. J Neurol Neurosurg Psychiatry 76: 1366-72 (Pubitemid 41360973)
36. Emsley HC, Smith CJ, Gavin CM, Georgiou RF, Vail A, Barberan EM, Hallenbeck JM, del Zoppo GJ, Rothwell NJ, Tyrrell PJ, Hopkins SJ (2003) An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis. J Neuroimmunol 139:93-101 (Pubitemid 36694395)
37. Ernst M, Jenkins BJ (2004) Acquiring signaling specificity from the cytokine receptor gp130. Trends Genet 20: 23-32 (Pubitemid 38032817)
38. Fassbender K, Schmidt R, Mossner R, Daffertshofer M, Hennerici M (1994) Pattern of activation of the hypothalamic-pituitary-adrenal axis in acute stroke. Relation to acute confusional state, extent of brain damage, and clinical outcome. Stroke 25:1105-8 (Pubitemid 24164746)
39. Ferrarese C, Mascarucci P, Zoia C, Cavarretta R, Frigo M, Begni B, Sarinella F, Frattola L, De Simoni MG (1999) Increased cytokine release from peripheral blood cells after acute stroke. J Cereb Blood Flow Metab 19:1004-9 (Pubitemid 30173723)
40. Fogal B, Hewett SJ (2008) Interleukin-1beta: a bridge between inflammation and excitotoxicity? J Neurochem 106:1-23
41. Fontaine V, Mohand-Said S, Hanoteau N, Fuchs C, Pfizenmaier K, Eisel U (2002) Neurodegenerative and neuroprotective effects of tumor necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2. J Neurosci 22:RC216
42. Gahring LC, Carlson NG, Kulmar RA, Rogers SW (1996) Neuronal expression of tumor necrosis factor alpha in the murine brain. Neuroimmunomodulation 3:289-303 (Pubitemid 27230990)
43. Galea J, Ogungbenro K, Hulme S, Greenhalgh A, Aarons L, Scarth S, Hutchinson P, Grainger S, King A, Hopkins SJ, Rothwell N, Tyrrell P (2011) Intravenous anakinra can achieve experimentally effective concentrations in the central nervous system within a therapeutic time window: results of a dose-ranging study. J Cereb Blood Flow Metab 31:439-47
44. Garcia JH, Liu KF, Relton JK (1995) Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion. Am J Pathol 147:1477-86
45. Gardoni F, Boraso M, Zianni E, Corsini E, Galli CL, Cattabeni F, Marinovich M, Di Luca M, Viviani B (2011) Distribution of interleukin-1 receptor complex at the synaptic membrane driven by interleukin-1beta and NMDA stimulation. J Neuroinflammation 8:14
46. Gary DS, Bruce-Keller AJ, Kindy MS, Mattson MP (1998) Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor. J Cereb Blood Flow Metab 18:1283-7 (Pubitemid 28559674)
47. Gelderblom M, Leypoldt F, Steinbach K, Behrens D, Choe CU, Siler DA, Arumugam TV, Orthey E, Gerloff C, Tolosa E, Magnus T (2009) Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 40:1849-57
48. Ginis I, Jaiswal R, Klimanis D, Liu J, Greenspon J, Hallenbeck JM (2002) TNF-alpha-induced tolerance to ischemic injury involves differential control of NFkappaB transactivation: the role of NF-kappaB association with p300 adaptor. J Cereb Blood Flow Metab 22:142-52 (Pubitemid 34135645)
49. Ginsberg MD (2008) Neuroprotection for ischemic stroke: past, present and future. Neuropharmacology 55:363-89
50. Greenfeder SA, Nunes P, Kwee L, Labow M, Chizzonite RA, Ju G (1995) Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex. J Biol Chem 270:13757-65
51. Gregersen R, Lambertsen K, Finsen B (2000) Microglia and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice. J Cereb Blood Flow Metab 20:53-65 (Pubitemid 30019830)
52. Hara H, Fink K, Endres M, Friedlander RM, Gagliardini V, Yuan J, Moskowitz MA (1997a) Attenuation of transient focal cerebral ischemic injury in transgenic mice expressing a mutant ICE inhibitory protein. J Cereb Blood Flow Metab 17:370-5 (Pubitemid 27188533)
53. Hara H, Friedlander RM, Gagliardini V, Ayata C, Fink K, Huang Z, Shimizu-Sasamata M, Yuan J, Moskowitz MA (1997b) Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc Natl Acad Sci USA 94: 2007-12 (Pubitemid 27113952)
54. Hata R, Maeda K, Hermann D, Mies G, Hossmann KA (2000a) Dynamics of regional brain metabolism and gene expression after middle cerebral artery occlusion in mice. J Cereb Blood Flow Metab 20:306-15 (Pubitemid 30108449)
55. Hata R, Maeda K, Hermann D, Mies G, Hossmann KA (2000b) Evolution of brain infarction after transient focal cerebral ischemia in mice. J Cereb Blood Flow Metab 20:937-46 (Pubitemid 30413677)
56. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F (2003) Principles of interleukin (IL)-6-type cytokine signaling and its regulation. Biochem J 374:1-20 (Pubitemid 37046923)
57. Heiss WD, Sobesky J (2008) Comparison of PET and DW/PW-MRI in acute ischemic stroke. Keio J Med 57:125-31
58. Herrmann O, Tarabin V, Suzuki S, Attigah N, Coserea I, Schneider A, Vogel J, Prinz S, Schwab S, Monyer H, Brombacher F, Schwaninger M (2003) Regulation of body temperature and neuroprotection by endogenous interleukin-6 in cerebral ischemia. J Cereb Blood Flow Metab 23:406-15 (Pubitemid 36403022)
59. Hill JK, Gunion-Rinker L, Kulhanek D, Lessov N, Kim S, Clark WM, Dixon MP, Nishi R, Stenzel-Poore MP, Eckenstein FP (1999) Temporal modulation of cytokine expression following focal cerebral ischemia in mice. Brain Res 820:45-54 (Pubitemid 29225477)
60. Hillhouse EW, Kida S, Iannotti F (1998) Middle cerebral artery occlusion in the rat causes a biphasic production of immunoreactive interleukin-1beta in the cerebral cortex. Neurosci Lett 249:177-9 (Pubitemid 28331544)
61. Hoehn M, Nicolay K, Franke C, van der Sanden B (2001) Application of magnetic resonance to animal models of cerebral ischemia. J Magn Reson Imaging 14:491-509 (Pubitemid 33029535)
62. Hossmann KA (1996) Pathophysiology and therapy of experimental stroke. Cell Mol Neurobiol 26:1057-83
63. Hossmann KA (2012) The two pathophysiologies of focal brain ischemia: implications for translational stroke research. J Cereb Blood Flow Metab; doi: 10.1038/jcbfm. 2011.186
64. Huang P, Chen CH, Yang YH, Lin RT, Lin FC, Liu CK (2006) Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: way to endeavor. Cerebrovasc Dis 22:423-8 (Pubitemid 44681119)
65. Hughes JL, Beech JS, Jones PS, Wang D, Menon DK, Baron JC (2010) Mapping selective neuronal loss and microglial activation in the salvaged neocortical penumbra in the rat. Neuroimage 49:19-31
66. Intiso D, Stampatore P, Zarrelli MM, Guerra GL, Arpaia G, Simone P, Tonali P, Beghi E (2003) Incidence of first-ever ischemic and hemorrhagic stroke in a well-defined community of southern Italy, 1993 to 1995. Eur J Neurol 10:559-65 (Pubitemid 38021472)
67. Jickling GC, Sharp FR (2011) Blood biomarkers of ischemic stroke. Neurotherapeutics 8:349-60
68. Kamimura D, Ishihara K, Hirano T (2003) IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev Physiol Biochem Pharmacol 149:1-38
69. Kim YD, Sohn NW, Kang C, Soh Y (2002) DNA array reveals altered gene expression in response to focal cerebral ischemia. Brain Res Bull 58:491-8 (Pubitemid 35286773)
70. Kohno T, Brewer MT, Baker SL, Schwartz PE, King MW, Hale KK, Squires CH, Thompson RC, Vannice JL (1990) A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor. Proc Natl Acad Sci USA 87:8331-5
71. Kriegler M, Perez C, DeFay K, Albert I, Lu SD (1988) A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell 53:45-53
72. Lambertsen KL, Clausen BH, Babcock AA, Gregersen R, Fenger C, Nielsen HH, Haugaard LS, Wirenfeldt M, Nielsen M, Dagnaes-Hansen F, Bluethmann H, Faergeman NJ, Meldgaard M, Deierborg T, Finsen B (2009) Microglia protect neurons against ischemia by synthesis of tumor necrosis factor. J Neurosci 29:1319-30
73. Lambertsen KL, Clausen BH, Fenger C, Wulf H, Owens T, Dagnaes-Hansen F, Meldgaard M, Finsen B (2007) Microglia and macrophages express tumor necrosis factor receptor p75 following middle cerebral artery occlusion in mice. Neuroscience 144:934-49 (Pubitemid 46019844)
74. Lambertsen KL, Gregersen R, Finsen B (2002) Microglialmacrophage synthesis of tumor necrosis factor after focal cerebral ischemia in mice is strain dependent. J Cereb Blood Flow Metab 22:785-97 (Pubitemid 34747596)
75. Lambertsen KL, Meldgaard M, Ladeby R, Finsen B (2005) A quantitative study of microglial-macrophage synthesis of tumor necrosis factor during acute and late focal cerebral ischemia in mice. J Cereb Blood Flow Metab 25:119-35 (Pubitemid 40096903)
76. Lang D, Knop J, Wesche H, Raffetseder U, Kurrle R, Boraschi D, Martin MU (1998) The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness. J Immunol 161:6871-7 (Pubitemid 28562232)
77. Lavine SD, Hofman FM, Zlokovic BV (1998) Circulating antibody against tumor necrosis factor-alpha protects rat brain from reperfusion injury. J Cereb Blood Flow Metab 18:52-8 (Pubitemid 28019011)
78. Lehrmann E, Christensen T, Zimmer J, Diemer NH, Finsen B (1997) Microglial and macrophage reactions mark progressive changes and define the penumbera in the rat neocortex and striatum after transient midddle cerebral artery occlusion. J Comp Neurol 386:41-76
79. Liu S, Levine SR, Winn HR (2010) Targeting ischemic penumbra: part I-from pathophysiology to therapeutic strategy. J Exp Stroke Transl Med 3:47-55
80. Liu T, Clark RK, McDonnell PC, Young PR, White RF, Barone FC, Feuerstein GZ (1994) Tumor necrosis factor-alpha expression in ischemic neurons. Stroke 25: 1481-8 (Pubitemid 24198599)
81. Liu T, McDonnell PC, Young PR, White RF, Siren AL, Hallenbeck JM, Barone FC, Feurstein GZ (1993) Interleukin-1 beta mRNA expression in ischemic rat cortex. Stroke 24:1746-50, discussion 1750-1751 Lo EH (2008) A new penumbra: transitioning from injury into repair after stroke. Nat Med 14:497-500
82. Loddick SA, Rothwell NJ (1996) Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. J Cereb Blood Flow Metab 16:932-40 (Pubitemid 26292060)
83. Loddick SA, Turnbull AV, Rothwell NJ (1998) Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat. J Cereb Blood Flow Metab 18:176-9 (Pubitemid 28082514)
84. Luheshi NM, Kovács KJ, Lopez-Castejon G, Brough D, Denes A (2012) Interleukin-1a expression precedes Il-1b after ischemic injury and is localised to areas of focal neuronal loss and penumbral tissues. J Neuroinflamm 8:186
85. Maas MB, Furie KL (2009) Molecular biomarkers in stroke diagnosis and prognosis. Biomark Med 3:363-83
86. Marchetti L, Klein M, Schlett K, Pfizenmaier K, Eisel UL (2004) Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-kappa B pathway. J Biol Chem 279:32869-81 (Pubitemid 39014747)
87. Matsuda S, Wen TC, Morita F, Otsuka H, Igase K, Yoshimura H, Sakanaka M (1996) Interleukin-6 prevents ischemia-induced learning disability and neuronal and synaptic loss in gerbils. Neurosci Lett 204:109-12 (Pubitemid 26053684)
88. Mattson MP, Goodman Y, Luo H, Fu W, Furukawa K (1997) Activation of NF-kappaB protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration. J Neurosci Res 49:681-97 (Pubitemid 27430168)
89. Mazzotta G, Sarchielli P, Caso V, Paciaroni M, Floridi A, Gallai V (2004) Different cytokine levels in thrombolysis patients as predictors for clinical outcome. Eur J Neurol 11:377-81 (Pubitemid 39272941)
90. McColl BW, Allan SM, Rothwell NJ (2009) Systemic infection, inflammation and acute ischemic stroke. Neuroscience 158:1049-61
91. McCoy MK, Tansey MG (2008) TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J Neuroinflammation 5:45
92. Moidunny S, Dias RB, Wesseling E, Sekino Y, Boddeke HW, Sebastiao AM, Biber K (2010) Interleukin-6-type cytokines in neuroprotection and neuromodulation: oncostatin M, but not leukemia inhibitory factor, requires neuronal adenosine A1 receptor function. J Neurochem 114:1667-77
93. Montaner J, Rovira A, Molina CA, Arenillas JF, Ribó M, Chacón P, Monasterio J, Alvarez-Sab?́n J (2003) Plasmatic level of neuroinflammatory markers predict the extent of diffusion-weighted image lesions in hyperacute stroke. J Cereb Blood Flow Metab 23:1403-7 (Pubitemid 38018258)
94. Mulcahy NJ, Ross J, Rothwell NJ, Loddick SA (2003) Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischaemia in the rat. Br J Pharmacol 140:471-6 (Pubitemid 37330491)
95. Nakanishi M, Niidome T, Matsuda S, Akaike A, Kihara T, Sugimoto H (2007) Microglia-derived interleukin-6 and leukaemia inhibitory factor promote astrocytic differentiation of neural stem/progenitor cells. Eur J Neurosci 25:649-58
96. Nawashiro H, Martin D, Hallenbeck JM (1997a) Inhibition of tumor necrosis factor and amelioration of brain infarction in mice. J Cereb Blood Flow Metab 17: 229-232 (Pubitemid 27085847)
97. Nawashiro H, Martin D, Hallenbeck JM (1997b) Neuroprotective effects of TNF binding protein in focal cerebral ischemia. Brain Res 778:265-71 (Pubitemid 28037406)
98. Nawashiro H, Tasaki K, Ruetzler CA, Hallenbeck JM (1997c) TNF-alpha pretreatment induces protective effects against focal cerebral ischemia in mice. J Cereb Blood Flow Metab 17:483-90 (Pubitemid 27250974)
99. Nophar Y, Kemper O, Brakebusch C, Englemann H, Zwang R, Aderka D, Holtmann H, Wallach D (1990) Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor. EMBO J 9: 3269-78
100. Offner H, Vandenbark AA, Hurn PD (2009) Effect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppression. Neuroscience 158:1098-11
101. Ohtaki H, Takaki A, Yin L, Dohi K, Nakamachi T, Matsunaga M, Horai B, Asano M, Iwakura Y, Shoida S (2003) Suppression if oxidative stress after transient focal ischemia in interleukin-1 knock out mice. Acta Neurochir Suppl 86:191-4
102. Ohtaki H, Yin L, Nakamachi T, Dohi K, Kudo Y, Makino R, Shioda S (2004) Expression of tumor necrosis factor alpha in nerve fibers and oligodendrocytes after transient focal ischemia in mice. Neurosci Lett 368:162-6 (Pubitemid 39194864)
103. Ormstad H, Aass HC, Lund-Sorensen N, Amthor KF, Sandvik L (2011) Serum levels of cytokines and Creactive protein in acute ischemic stroke patients, and their relationship to stroke lateralization, type, and infarct volume. J Neurol 258:677-85
104. Parker LC, Luheshi GN, Rothwell NJ, Pinteaux E (2002) IL-1 beta signaling in glial cells in wildtype and IL-1RI deficient mice. Br J Pharmacol 136:312-20 (Pubitemid 34587679)
105. Perini F, Morra M, Alecci M, Galloni E, Marchi M, Toso V (2001) Temporal profile of serum anti-inflammatory and pro-inflammatory interleukins in acute ischemic stroke patients. Neurol Sci 22:289-96 (Pubitemid 34071562)
106. Pinteaux E, Rothwell NJ, Boutin H (2006) Neuroprotective action of endogenous interleukin-1 receptor antagonist (IL-1ra) are mediated by glia. Glia 53:551-6
107. Pradillo JM, Romera C, Hurtado O, Cardenas A, Moro MA, Leza JC, Davalos A, Castillo J, Lorenzo P, Lizasoain I (2005) TNFR1 upregulation mediates tolerance after brain ischemic preconditioning. J Cereb Blood Flow Metab 25:193-203 (Pubitemid 40171201)
108. Relton JK, Martin D, Thompson RC, Russell DA (1996) Peripheral administration of Interleukin-1 Receptor antagonist inhibits brain damage after focal cerebral ischemia in the rat. Exp Neurol 138:206-13 (Pubitemid 26135199)
109. Rivers CS, Wardlaw JM, Armitage PA, Bastin ME, Carpenter TK, Cvoro V, Hand PJ, Dennis MS (2006) Persistent infarct hyperintensity on diffusion-weighted imaging late after stroke indicates heterogeneous, delayed, infarct evolution. Stroke 37:1418-23 (Pubitemid 44305719)
110. Romera C, Hurtado O, Botella SH, Lizasoain I, Cardenas A, Fernandez-Tome P, Leza JC, Lorenzo P, Moro MA (2004) In vitro ischemic tolerance involves upregulation of glutamate transport partly mediated by the TACE/ADAM17-tumor necrosis factor-alpha pathway. J Neurosci 24:1350-7 (Pubitemid 38222985)
111. Sairanen T, Carpen O, Karjalainen-Lindsberg ML, Paetau A, Turpeinen U, Kaste M, Lindsberg PJ (2001) Evolution of cerebral tumor necrosis factor-alpha production during human ischemic stroke. Stroke 32:1750-8
112. Saper CB, Sawchenko PE (2003) Magic peptides, magic antibodies: guidelines for appropriate controls for immunohistochemistry. J Comp Neurol 465:161-3 (Pubitemid 37100126)
113. Scheller J, Rose-John S (2006) Interleukin-6 and its receptor: from bench to bedside. Med Microbiol Immunol 195:173-83 (Pubitemid 44600378)
114. Schielke GP, Yang GY, Shivers BD, Betz AL (1998) Reduced ischemic brain injury in interleukin-1 beta converting enzyme-deficient mice. J Cereb Blood Flow Metab 18:180-5 (Pubitemid 28082515)
115. Schindler R, Mancilla J, Endres S, Ghorbani R, Clark SC, Dinarello CA (1990) Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 75:40-7 (Pubitemid 20031487)
116. Schwamm LH, Koroshetz WJ, Sorensen AG, Wang B, Copen WA, Budzik R, Rordorf G, Buonanno FS, Schaefer PW, Gonzalez RG (1998) Time course of lesion development in patients with acute stroke: serial diffusion-and hemodynamic-weighted magnetic resonance imaging. Stroke 29:2268-76 (Pubitemid 28511943)
117. Sharp FR, Jickling GC, Stamova B, Tian Y, Zhan X, Liu D, Kuczynski B, Cox CD, Ander BP (2011) Molecular markers and mechanisms of stroke: RNA studies of blood in animals and humans. J Cereb Blood Flow Metab 31:1513-31
118. Simi A, Tsakiri N, Wang P, Rothwell NJ (2007) Interleukin-1 and inflammatory neurodegeneration. Biochem Soc Trans 35:1122-6 (Pubitemid 350206443)
119. Smith CJ, Emsley HC, Gavin CM, Georgiou RF, Vail A, Barberan EM, del Zoppo GJ, Hallenbeck JM, Rothwell NJ, Hopkins SJ, Tyrrell PJ (2004) Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol 4:2
120. Sommer C (2010) Histology and infarct volume determination. In Rodent Models of Stroke Vol. 47, (Dirnagl U, ed) Springer New York Dordrecht Heidelberg London: Humana Press, 213-26
121. Sotgiu S, Zanda B, Marchetti B, Fois ML, Arru G, Pes GM, Salaris FS, Arru A, Pirisi A, Rosati G (2006) Inflammatory biomarkers in blood of patients with acute brain ischemia. Eur J Neurol 13:505-13 (Pubitemid 43823367)
122. St Pierre M, Reeh PW, Zimmermann K (2009) Differential effects of TRPV channel block on polymodal activation of rat cutaneous nociceptors in vitro. Exp Brain Res 196: 31-44
123. Sun Y, Lu CJ, Lin CH, Wen LL (2009) Interleukin-1beta is increased in the cerebrospinal fluid of patients with small infarcts. Eur J Neurol 16:858-63
124. Suzuki S, Tanaka K, Nogawa S, Nagata E, Ito D, Dembo T, Fukuuchi Y (1999) Temporal profile and cellular localization of interleukin-6 protein after focal cerebral ischemia in rats. J Cereb Blood Flow Metab 19:1256-62 (Pubitemid 30176454)
125. Suzuki S, Tanaka K, Suzuki N (2009) Ambivalent aspects of interleukin-6 in cerebral ischemia: inflammatory versus neurotrophic aspects. J Cereb Blood Flow Metab 29: 464-479
126. Suzuki S, Yamashita T, Tanaka K, Hattori H, Sawamoto K, Okano H, Suzuki N (2005) Activation of cytokine signaling through leukemia inhibitory factor receptor (LIFR)/gp130 attenuates ischemic brain injury in rats. J Cereb Blood Flow Metab 25:685-93 (Pubitemid 40705604)
127. Taoufik E, Valable S, Muller GJ, Roberts ML, Divoux D, Tinel A, Voulgari-Kokota A, Tseveleki V, Altruda F, Lassmann H, Petit E, Probert L (2007) FLIP(L) protects neurons against in vivo ischemia and in vitro glucose deprivation-induced cell death. J Neurosci 27:6633-46 (Pubitemid 46983433)
128. Tarkowski E, Rosengren L, Blomstrand C, Wikkelso C, Jensen C, Ekholm S, Tarkowski A (1995) Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke 26:1393-8
129. Tarkowski E, Rosengren L, Blomstrand C, Wikkelso C, Jensen C, Ekholm S, Tarkowski A (1997) Intrathecal release of pro-and anti-inflammatory cytokines during stroke. Clin Exp Immunol 110:492-9 (Pubitemid 27525284)
130. Thacker MA, Clark AK, Marchand F, McMahon SB (2007) Pathophysiology of peripheral neuropathic pain: immune cells and molecules. Anesth Analg 105:838-47 (Pubitemid 47300869)
131. Thornton P, McColl MW, Greenhalgh A, Denes A, Allan SM, Rothwell NJ (2010) Platelet interleukin-1a drives cerebrovascular inflammation. Blood 115:3632-9
132. Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW (1994) Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 83: 113-8 (Pubitemid 24016522)
133. Tomimoto H, Akiguchi I, Wakita H, Kinoshita A, Ikemoto A, Nakamura S, Kimura J (1996) Glial expression of cytokines in the brains of cerebrovascular disease patients. Acta Neuropathol 92:281-7 (Pubitemid 26278959)
134. Touzani O, Boutin H, LeFeuvre R, Parker L, Miller A, Luheshi G, Rothwell N (2002) Interleukin-1 influences ischemic brain damage in the mouse independently of the interleukin-1 type I receptor. J Neurosci 22:38-43 (Pubitemid 34033481)
135. Vila N, Castillo J, Davalos A, Chamorro A (2000) Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 31:2325-9
136. Vitkovic L, Bockaert J, Jacque C (2000) 'Inflammatory' cytokines: neuromodulators in normal brain? J Neurochem 74:457-71 (Pubitemid 30053717)
137. Viviani B, Bartesaghi S, Gardoni F, Vezzani A, Behrens MM, Bartfai T, Binaglia M, Corsini E, Di Luca M, Galli CL, Marinovich M (2003) Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci 23:8692-700 (Pubitemid 37176649)
138. Waje-Andreassen U, Krakenes J, Ulvestad E, Thomassen L, Myhr KM, Aarseth J, Vedeler CA (2005) IL-6: an early marker for outcome in acute ischemic stroke. Acta Neurol Scand 111:360-5 (Pubitemid 40705305)
139. Wang X, Feuerstein GZ, Xu L, Wang H, Schumacher WA, Ogletree ML, Taub R, Duan JJ, Decicco CP, Liu RQ (2004) Inhibition of tumor necrosis factor-alpha-converting enzyme by a selective antagonist protects brain from focal ischemic injury in rats. Mol Pharmacol 65:890-6 (Pubitemid 38420494)
140. Wang X, Li X, Currie RW, Willette RN, Barone FC, Feuerstein GZ (2000) Application of real-time polymerase chain reaction to quantitate induced expression of interleukin-1beta mRNA in ischemic brain tolerance. J Neurosci Res 59:238-46 (Pubitemid 30036897)
141. Wang X, Yue TL, Barone FC, White RF, Gagnon RC, Feuerstein GZ (1994) Concomitant cortical expression of TNF-alpha and IL-1 beta mRNAs follows early response gene expression in transient focal ischemia. Mol Chem Neuropathol 23:103-14
142. Wang X, Yue TL, Young PR, Barone FC, Feuerstein GZ (1995) Expression of interleukin-6, c-fos, and zif268 mRNAs in rat ischemic cortex. J Cereb Blood Flow Metab 15:166-71
143. Weinstein PR, Hong S, Sharp FR (2004) Molecular identification of the ischemic penumbra. Stroke 35: 2666-70 (Pubitemid 39458363)
144. Whiteley W, Jackson C, Lewis S, Lowe G, Rumley A, Sandercock P, Wardlaw J, Dennis M, Sudlow C (2009) Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6. PLoS Med 6:e1000145
145. Yamasaki Y, Matsuura N, Shozuhara H, Onodera H, Itoyama Y, Kogure K (1995) Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke 26:676-80, discussion 681
146. Yang GY, Gong C, Qin Z, Liu XH, Lorris Betz A (1999) Tumor necrosis factor alpha expression produces increased blood-brain barrier permeability following temporary focal cerebral ischemia in mice. Brain Res Mol Brain Res 69:135-43 (Pubitemid 29238194)
147. Yang GY, Gong C, Qin Z, Ye W, Mao Y, Bertz AL (1998) Inhibition of TNFalpha attenuates infarct volume and ICAM-1 expression in ischemic mouse brain. Neuroreport 9:2131-4 (Pubitemid 28300580)
148. Yin L, Ohtaki H, Nakamachi T, Kudo Y, Makino R, Shioda S (2004) Delayed expressed TNFR1 co-localize with ICAM-1 in astrocyte in mice brain after transient focal ischemia. Neurosci Lett 370:30-5 (Pubitemid 39369851)
149. Zaremba J, Losy J (2001) Early TNF-alpha levels correlate with ischaemic stroke severity. Acta Neurol Scand 104:288-95 (Pubitemid 32977149)
150. Zhang Z, Chopp M, Powers C (1997) Temporal profile of microglial response following transient (2 hours) middle cerebral artery occlusion. Brain Res 744:189-98 (Pubitemid 27032335)